Both deputy directors at the key FDA center that oversees regulation of cancer drugs plan on leaving the agency ...

Eli Lilly said on Tuesday it had sued two mass compounders for selling unapproved products that contain tirzepatide, the main ...

There’s no question, however, that the decision to abandon the twice-daily version introduces a significant delay to Pfizer’s plans to enter the obesity market, which has been transformed in ...

Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as ...

Dansey was chief medical officer of ADC specialist Seagen, which Pfizer acquired for $43 billion last year, and he plans to retire ... referencing a disappointing obesity programme.

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...

Are we truly on the brink of a cure for obesity? Or could neglecting the root causes risk worsening the very problems we seek ...

The survey predicted the increase would happen within the next six months. Other industry news is on health care access in rural areas; Pfizer's alleged attempt to avoid taxes; and more.

Life coaching requires no mental health education, and it sometimes attracts former therapists who have lost their license to practice, reports ProPublica. Other states making news are New York, Iowa, ...

The Weight Loss Drugs Market is poised for significant growth from 2025 to 2035. With increasing obesity rates, rising ...

Pfizer's stock is cheap but faces operational challenges. Analyze its valuation and performance to make informed investment ...